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dry DMLA. Dyschromatopsia was confirmed by poor results on 
Ishihara test (1/13 OU). Computerized visual field results revealed 
nonspecific diffuse alterations. Full-field electroretinogram (ERG) 
showed moderate diffuse rod and cone dysfunction. Visual symp-
toms progressively improved over the next 2 months, but ERG did 
not. Complete resolution was not expected due to the pre-existing 
eye disease. The patient was finally discharged home after a 5-week 
hospital stay.
Conclusion: Digoxin intoxication can go unrecognized by clinicians, 
even in a typical presentation. The range of potential visual symp-
toms is far greater than isolated xanthopsia (yellow vision) classically 
described in textbooks. Newly introduced drugs and all symptoms 
must be actively sought after, because they significantly affect quality 
of life and global functioning, especially in the elderly population, 
most liable not to mention them.
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Introduction: Worldwide data indicate that antibiotics are frequently 
used inappropriately. Inappropriate use of antibacterial agents may 
lead not only to unfavorable medical consequences but also to sub-
stantial ecological and economic consequences. The objective of this 
study was to investigate the extent of storage and wastage of antibac-
terial agents in households in Novi Sad, Serbia.
Patients (or Materials) and Methods: The study was performed in an 
8-month period (December 2011–July 2012) among households in 
Novi Sad, Serbia. The households were randomly selected from the 
telephone directory. The investigator informed the respondents about 
the aim of the study and asked if they agreed to participate. After 
that, the interviewer performed the survey by visited each household. 
During the visit, the presence or absence of antibiotics was checked, 
and the respondent was interviewed.
Results: The total number of antibacterial agents in the 383 surveyed 
households was 318, constituting 7.3% of the total stored medica-
tions. From 383 families included in the study, antibiotics were found 
in 178 (46.5%). In 13 (7.3%) families were found > 1 pack of the 
same antibiotics. The median number of antibacterial agents per 
household was 1 (range, 1-5). The most common antibacterial agents 
encountered were cephalexin (21.4%) and amoxicillin (18.8%), fol-
lowed by doxycycline, amoxicillin/clavulanic acid, and sulfameth-
oxazole/ trimethoprim (10.1%). There was no statistically significant 
difference in the number of antibacterial agents between families with 
or without children under 12 years in the family (P = 0.218). The 
number of family members and the number of medications in the 
family were significantly and positively (P = 0.014 and P < 0.001, 
respectively) correlated with the number of antibacterial agents found 
in the households. Wasted antibacterial agents, defined as those that 
had expired, were 20.8%. The percentage of antibacterial agents 
that were not currently in use was 85.2%. Estimated total value of 
antibacterial agents found in the study was 892.52€ , approximately 
2.33€ per household. The total wastage of antibacterial agents was 
valued at 166.97€ , approximately 0.44€ per household.
Conclusion: Antibacterial agents were commonly encountered in 
Serbian households, and a relatively large percentage was being 
wasted. Informational and educational activities aimed at improv-
ing the public’s knowledge about antimicrobials play the leading role 
in reducing imprudent use of antibiotics.
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Introduction: Atypical antipsychotics (AP) are increasingly being 
used in children and adolescents for the treatment of psychiatric 
disorders such as psychoses, autism, attention-deficit/hyperactivity 
disorder (ADHD), and aggressive behavior. Atypical AP may cause 
QT prolongation on the electrocardiogram (ECG), which predisposes 
patients to an increased risk of developing threatening ventricular 
arrhythmias. Although this phenomenon has been exhaustively 
reported in adults, few studies investigated the safety of these drugs 
in pediatric patients.
Patients (or Materials) and Methods: We performed an open-label, 
prospective study to assess the arrhythmic risk of aripiprazole and 
risperidone in pediatrics. A total of 60 patients (55 M/5 F; mean age, 
11.8 [3.27] years; range, 3–17 years), receiving a new prescription of 
aripiprazole or risperidone in monotherapy underwent a standard 
ECG before and after 2 months from the beginning of antipsychotic 
treatment. Basal and posttreatment ECG parameters, including mean 
QT (QTc) and QT dispersion (QTd) interval duration, were com-
pared within treatment groups.
Results: Twenty-nine patients were treated with aripiprazole (mean 
dosage, 7.8 [3.2] mg/d) and 31 with risperidone (mean dosage, 1.7 
[1.1] mg/d). Although no patients exhibited pathologic values of QTc 
or QTd, treatment with risperidone was associated with a significant 
increase of both QTc and QTd values (407.4 [11.9] ms vs 412.4 
[10.3] ms, P = 0.03; and 40.0 [4.4] ms vs 44.7 [5.5] ms, P = 0.0001, 
respectively). Conversely, treatment with aripiprazole was associated 
with a statistically significant increase of QTd (40.6 [6.5] ms vs 46.3 
[7.2] ms, P = 0.0001) in presence of an unmodified QTc. Moreover, 
in patients treated with aripiprazole, a significant decrease in heart 
rate was observed after treatment (90.0 [21.2] beats/min vs 79.8 
[19.3] beats/min; P = 0.0003).
Conclusion: The present study provided important advances in the 
assessment of the cardiologic safety of second-generation AP dur-
ing the pediatric age. Indeed, the treatment with risperidone and 
aripiprazole was associated with modifications of the QT tract on 
ECG, thus indicating that these drugs can exert a substantial effect on 
the ventricular repolarization. Our study remarks the importance to 
perform an ECG examination in all patients undergoing AP therapy. 
Both QTc and QTd evaluation should be performed to warranty 
a reliable assessment of drug-induced QT prolongation. Caution 
should also be exercised in prescribing aripiprazole in patients at 
risk of bradycardia.
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Introduction: DILI differs across geographical areas due to differen-
tial drug polices, prescription habits, drug consumption, and genetic 
factors. In this study, we have compared DILI cases included in the 
recently established Latin American DILI Network with those in 
the Spanish DILI Registry and the US Drug-Induced Liver Injury 
Network to identify differences in phenotypic presentations and 
causative agents.
Patients (or Materials) and Methods: Demographic, clinical 
parameters, and causative agents were compared between 98 Latin 
American, 851 Spanish, and 300 US DILI cases.
Results: The Latin American cases had a mean age of 54 years with 
a predominance of females (61%), whereas mean age and female 
proportion in the Spanish and US DILI cases were 54 years with 49% 
females and 48 years with 60% females, respectively. The most com-
mon type of liver damage in all 3 registries was hepatocellular injury. 
Jaundice was frequently seen in the registries, with 70%, 66%, and 
69% of the Latin American, Spanish, and US DILI cases, respectively. 
Hospitalization occurred in 51% of the Latin American DILI cases, 
with 57% and 60% of the Spanish and US cases requiring hospi-
talization. Liver-related death or liver transplantation occurred in 
5.1%, 3.6%, and 6.0% of the Latin American, Spanish, and US cases, 
respectively. The main causative agents in Latin America included 
nimesulide, diclofenac, nitrofurantoin, cyproterone acetate, and vari-
ous herbal remedies, whereas amoxicillin-clavulanate predominated 
in the other 2 registries, followed by ibuprofen in Spain and nitro-
furantoin in the United States.
Conclusion: The Latin American DILI cases demonstrate similar 
phenotypic characteristics as observed in registers outside Latin 
America with respect to type of injury and severity. Female sex 
predominates in the Latin America and US registries. With regard 
to causative agents, elevated representation of NSAIDs, hormonal 
treatments, and herbal remedies were seen in Latin America, whereas 
antibiotics were more common causes of DILI in Spain and the 
United States.
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Introduction: We report a case of cefepime intoxication with acute 
severe neurologic symptoms, which was treated by temporary hemo-
dialysis.
Patients (or Materials) and Methods: Cefepime 2 g BID for endo-
vascular prosthesis infection was prescribed to a frail, chronically ill 
88-year-old woman with a serum creatinine of 199 µmol/L and an 
estimated creatinine clearance of 13 mL/min (Cockroft formula). Two 
days later, she was transferred to a neurocritical care unit because 
of acute aphasia, myoclonic jerks, and delirium with a Glasgow 
coma scale score of 12/15. The following day, in the absence of 
other causes, cefepime intoxication was hypothesized, and cefepime 
was withdrawn after a total of 7 doses = 14 g. Over the next 24 
hours, two 3-hour hemodialysis (HD) sessions were performed under 
cefepime concentration monitoring.
Results: Cefepime plasma levels were measured by liquid chroma-
tography/mass spectrometry. There is no validated reference range, 
but a study (Chapuis T et al, Critical Care, 2010) found a 50% risk 
of neurotoxicity with residual levels > 15 mg/L. In our patient, levels 
were 83.3 mg/L 10 hours after last dose, 24.1 mg/L immediately after 
the first HD session, 13.4 mg/L immediately before the second HD 
session, and 2.5 mg/L immediately after the second HD session. The 
patient made a full clinical recovery over the next 48 hours. The 70% 
to 80% fall in plasmatic levels observed during each HD session is 
in accordance with literature data (Schmaldienst S et al, Eur J Clin 
Pharmacol, 2000, and Manyor LM et al, Pharmacotherapy, 2008). 
According to kinetic simulation, cefepime dropped at a concentration 
< 15 mg/L 15 hours earlier with HD than it would have without.
Conclusion: Neuropsychiatric adverse effects of beta-lactam antibi-
otics can be easily overlooked by clinicians. One should be especially 
cautious with their use in very old and frail patients in whom plasma 
creatinine poorly estimates renal function and cognitive impair-
ment is highly prevalent. Temporary hemodialysis effectively clears 
cefepime, but its role in hastening clinical recovery may be limited.
Disclosure of Interest: None declared.
PP024—ADVERSE DRUG EVENTS AND 
MEDICATION ERRORS RELATED TO 
PSYCHOTROPIC DRUGS IN PATIENTS 
PRESENTING AT AN EMERGENCY DEPARTMENT
B. Pfistermeister1*; H. Dormann2; A. Patapovas3; F. Meier4;  
F. Müller1; A. Sonst2; B. Plank-Kiegele1; R. Vogler1; O. Schöffski4; 
T. Bürkle3; and R. Maas1
1Institute of Experimental and Clinical Pharmacology and 
Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 
Erlangen; 2Emergency Department, Klinikum Fürth, Fürth; 
3Department of Medical Informatics, Friedrich-Alexander-
Universität Erlangen-Nürnberg, Erlangen; and 4Chair of Health 
Management, Friedrich-Alexander-Universität Erlangen-Nürnberg, 
Nürnberg, Germany
Introduction: Hospitalization due to adverse drug events (ADE) is a 
well-known problem. According to the literature ADE are the reason 
for ~5% of hospitalizations. Recent pharmacoepidemiologic studies 
raised concern regarding the long-term safety of antipsychotic and 
antidepressant drugs. It was the aim to analyze the involvement of 
psychotropic drugs in ADE of patients presenting at an emergency 
department (ED).
Patients (or Materials) and Methods: In this prospective observa-
tional study, nontraumatic patients presenting at the ED of a tertiary 
care university teaching hospital were evaluated in 3 study phases by 
intensive chart review by an interdisciplinary expert panel to detect 
and classify all ADE.
